FDA inspection
Intas Pharmaceuticals Limited: FDA inspection ending Feb 14, 2025
FDA inspection 1281854 · Official Action Indicated (OAI) · Moraiya
Key facts
| Inspection ID | 1281854 |
|---|---|
| Firm | Intas Pharmaceuticals Limited |
| FEI number | 3007277149 |
| Address | Plot 423/P/A, Sarkhej - Bavla Highway |
| City | Moraiya |
| Fiscal year | 2025 |
| Inspection end date | Feb 14, 2025 |
| Classification | Official Action Indicated (OAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data